Callan JMB Announces Closing of $5.12 Million Initial Public Offering
February 06 2025 - 4:29PM
Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an
integrative logistics company empowering the healthcare industry
and emergency management agencies through exceptional fulfillment,
storage, monitoring, and cold chain logistics services, today
announced the closing of its previously announced initial public
offering (the “
Offering”) of 1,280,000 shares (the
“
Shares”) of common stock (“
Common
Stock”) at an initial public offering price of
$4.00 per Share for a total of approximately
$5,120,000 of gross proceeds to the Company before deducting
underwriting discounts and commissions and estimated offering
expenses payable by the Company. In addition, Callan has granted
the underwriters a 45-day option to purchase, at the public
offering price, up to an additional 192,000 shares of Common Stock
at the public offering price, less the underwriting discounts and
commissions.
The shares began trading on the Nasdaq Capital
Market on February 5, 2025, under the ticker symbol “CJMB”. The
Company intends to use the net proceeds of the Offering primarily
for sales support, marketing, customer expansion and general
corporate purposes, including working capital.
Alexander Capital, L.P.
(“Alexander”) acted as the managing underwriter
and sole book runner for the Offering. Paulson Investment Company,
LLC and Bancroft Capital, LLC acted as co-managers for the
Offering. Sichenzia Ross Ference Carmel LLP served as counsel to
the Company, and Sullivan & Worcester LLP served as counsel to
Alexander in connection with the Offering.
A registration statement on Form S-1, as amended
(File No. 333-282879), relating to the Shares described above was
filed with the U.S. Securities and Exchange Commission
(“SEC”) and was declared effective
on February 4, 2025. The Offering was made only by means of a
prospectus. A copy of the final prospectus relating to the Offering
may be obtained from Alexander Capital, L.P., via
email: info@alexandercapitallp.com, or by
calling +1 (212) 687-5650, or by standard mail at Alexander Capital
L.P., 10 Drs James Parker Blvd, Suite 202 Red Bank, New Jersey
07701, Attention: Equity Capital Markets. In addition, a copy of
the final prospectus relating to the Offering may be obtained via
the SEC’s website at www.sec.gov.
Before you invest, you should read the
prospectus and other documents the Company has filed or will file
with the SEC for more complete information about the Company and
the Offering. This press release shall not constitute an offer to
sell or the solicitation of an offer to buy these securities, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. Any offers,
solicitations, or offers to buy, or any sales of securities will be
made in accordance with the registration requirements of the
Securities Act of 1933, as amended.
About Callan JMBCallan JMB is
an integrative logistics company empowering the healthcare industry
and emergency management agencies through exceptional fulfillment,
storage, monitoring, and cold chain logistics services to secure
medical materials and protect patients and communities with
compliant, safe, and effective medicines. Our combined expertise in
supply chain logistics, thermodynamics, biologics, inventory
management, regulatory compliance and emergency preparedness is
unparalleled in the industry. We offer excellence in client
experience with customizable interfaces, next-level reliability in
shipping and environmental sustainability in our specialty
packaging.
Forward Looking Statements:This
press release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) (which Sections were adopted
as part of the Private Securities Litigation Reform Act of 1995).
Statements preceded by, followed by or that otherwise include the
words “believe,” “anticipate,” “estimate,” “expect,” “intend,”
“plan,” “project,” “prospects,” “outlook,” and similar words or
expressions, or future or conditional verbs, such as “will,”
“should,” “would,” “may,” and “could,” are generally
forward-looking in nature and not historical facts. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's
actual results, performance, or achievements to be materially
different from any anticipated results, performance, or
achievements for many reasons. The Company disclaims any intention
to, and undertakes no obligation to, revise any forward-looking
statements, whether as a result of new information, a future event,
or otherwise. For additional risks and uncertainties that could
impact the Company's forward-looking statements, please see the
Company's Registration Statement Under the Securities Act of 1933
on Form S-1, including but not limited to the discussion under
“Risk Factors” therein, which the Company filed with the SEC and
which may be viewed at http://www.sec.gov/.
Investor Contacts:Valter Pinto,
Managing DirectorKCSA Strategic
CommunicationsCallanJMB@kcsa.com212.896.1254
Callan JMB (NASDAQ:CJMB)
Historical Stock Chart
From Jan 2025 to Feb 2025
Callan JMB (NASDAQ:CJMB)
Historical Stock Chart
From Feb 2024 to Feb 2025